TABLE 2.
Characteristics of seven P. aeruginosa isolates tested for carbapenemase production
| No of isolate | Date of isolation (mo/day/yr) | Department | Material | MIC (μg/ml) ofa:
|
blaVIM status | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IM | ME | CZ | CF | AT | CP | GM | AN | PI-TZb | |||||
| 4784 | 06/20/96 | C-Surgical | Blood | >128 | >128 | >128 | >128 | 32 | 64 | >128 | >128 | >128 | + |
| 4824 | 08/18/96 | A-ICUc | Wound | >128 | >128 | >128 | >128 | 64 | 64 | 128 | >128 | >128 | + |
| 4880 | 10/11/96 | C-ICU | Wound | 128 | 0.5 | >128 | >128 | 32 | 16 | 128 | 128 | >128 | − |
| 4956 | 01/25/97 | A-ICU | Bronchial | >128 | >128 | >128 | >128 | 64 | 128 | >128 | >128 | >128 | + |
| 174 | 06/12/97 | B-Surgical | Urine | >128 | >128 | >128 | >128 | 32 | 64 | 128 | 128 | >128 | + |
| 388 | 10/03/97 | Dialysis Unit | Blood | >128 | 128 | >128 | >128 | 32 | 64 | 128 | 128 | 128 | + |
| 556 | 03/02/98 | C-Surgical | Wound | >128 | >128 | >128 | >128 | 32 | 128 | 128 | 128 | >128 | + |
a
IM, imipenem; ME, meropenem; CZ, ceftazidime; CF, cefepime; AT, aztreonam; CP, ciprofloxacin; GM, gentamicin; AN, amikacin; PI-TZ, piperacillin-tazobactam.
b
Tazobactam tested at a fixed concentration of 4 μg/ml.
c
ICU, intensive-care unit.